Isabelle is ECPC's Projects Coordinator / Manager and is currently the appointed executive body for all EU funded projects participating in several European Union's Research and Innovation framework programmes in addition to working on 3 principal EU Policy files: the European Cross Border Health Directive, the General Data Protection Regulation, and Health Technology Assessment. She holds a double Bachelor of Science in Pharmacy and Pharmaceutical Sciences, a Master degree in Public Health, in addition to a post-master in European Studies specialising in EU Policy & Project Management. Isabelle is a USAID Training Future Leaders Scholarship recipient, a Golden Key International Honour Society member, and a EUPATI Scholar who has dedicated the past 10 years of her life to patients. She has previously worked with the United Nations (UN) and the European Civil Protection and Humanitarian Aid Operations (ECHO), among others around the globe. Isabelle is an active member of the General Assembly of the Worldwide Innovative Networking (WIN) Consortium, the European Society of Medical Oncology (ESMO), the European Commission's Health Technology Assessment (HTA) Stakeholder Pool, the Health Technology Assessment International (HTAi), and the BBMRI-ERIC Stakeholder Forum, as well as, an elected representative of the European Patient Group (ePAG) for the European Refrence Network (ERN) on rare adult solid tumours. Isabelle is Romanian and identifies as a citizen of the world. She speaks fluent English, Romanian, Arabic, a good knowledge of French and has basic understanding of Spanish and Italian.
Community & Communications Manager
Anna is ECPC's Community & Communications Manager. She holds one Bachelor's degree in European Studies, another in Political Science, and a Master in Contemporary European Studies and European Politics from the University of Sussex in Great Britain. She gained her professional experience and obtained a deep understanding of the healthcare sector while she worked for two worldwide pharmaceutical companies followed by a practice in a Public Relations agency, where she was responsible for developing and implementing health and disease awareness campaigns accompanied by proactive and reactive media relations. Anna has a substantial experience in supporting patient organisations, such as the Polish Cancer Patient Coalition, Melanoma Academy, Amazons, The Star of Hope Foundation and the Foundation for Social Education. As part of her work in managing the ECPC community of patient organisations, Anna is an active member of the World Pancreatic Cancer Coalition, Pancreatic Cancer Europe, and the Make Sense of Head & Neck Cancer campaign. She connects the European Society for Medical Oncology (ESMO), as well as, the European Medicines Agency (EMA) to cancer patient organisations throughout Europe. She also coordinates ECPC's Working Group on Bladder Cancer, ECPC's Annual Congress, ECPC's newsletter, and ECPC's social media channels. Anna is a positive and committed Polish national, who speaks fluent Polish, English and has a good knowledge of French.
With more than nine years of experience in the field of communication and project management (especially in the field of public policy contracts), Jiska has a large amount of experience in managing and coordinating budgets, contracts, people and events. As a Dutch national, she speaks Dutch and English fluently and has a good knowledge of German, French as well as some basic knowledge of Spanish.
Rafal Swierzewski has been involved in patient advocacy for ten years as both a scientist and cancer survivor. He earned his PhD in 2006 by examining the physical and chemical properties of new chemotherapy compounds. He served on ECPC's Board from 2013 to 2016. He currently represents the European Cancer Patient Coalition in the European Medicines Agency (AMA) together with the Vice-President of the European Cancer Patient Coalition. Through the European Medicines Agency, he has been involved in various projects, such as Adaptive Pathways, ADVANCE and WEBRADR. Rafal also represents patients' interests in the European Union’s clinical trial portal and database of stakeholder groups created within the European Medicines Agency to construct new systems for implementing European regulations on clinical trials and clinical data. Rafal speaks Polish and English.